Masimo Products To Boost India-Based NU Hospitals' Systems

By Zacks Investment ResearchStock MarketsFeb 26, 2018 09:38PM ET

www.investing.com/analysis/masimo-products-to-boost-indiabased-nu-hospitals-systems-200294589

Masimo Products To Boost India-Based NU Hospitals' Systems

By Zacks Investment Research | Feb 26, 2018 09:38PM ET

Saved. See Saved Items.

This article has already been saved in your Saved Items

FMC

+0.74%

Add to/Remove from Watchlist

ATHN

0.00%

Add to/Remove from Watchlist

MASI

-1.38%

Add to/Remove from Watchlist

-2.07%

Add to/Remove from Watchlist

CNC

+3.21%

Add to/Remove from Watchlist

Masimo Corporation (NASDAQ:MASI) recently announced that its technologies will be integrated in NU Hospitals, a Bangalore-based nephrology care center in India. This development is in line with the company’s focus on expanding in India.

Per the deal, NU Hospitals is going to incorporate a number of Masimo technologies in its operating rooms (OR), intensive care units (ICUs), dialysis beds and general wards.

NU Hospitals’ ORs will be equipped with Masimo Root Patient Monitoring and Connectivity Hubs and Radical-7 Pulse CO-Oximeters. These monitors will include noninvasive, continuous hemoglobin monitoring (SpHb), a Masimo rainbow parameter, Masimo Open Connect (MOC-9) technology and SedLine brain function monitoring.

Masimo Corporation Price and Consensus

Masimo Corporation Price and Consensus | Masimo Corporation Quote

Patients at NU Hospitals will be constantly monitored using a variety of bedside devices like Root with Noninvasive Blood Pressure and Temperature and Rad-97 Pulse CO-Oximeters. Measurements will include SpHb, SET Measure-through Motion and Low Perfusion pulse oximetry. Furthermore, Pleth variability index (PVi) monitoring has been adopted for dialysis patients to help in optimizing fluid management.

Developments in India & Emerging Economies

In recent times, Masimo has made several developments in India.

Last December, Artemis Hospital, a Gurgaon-based multi-specialty hospital in Delhi, India, adopted Masimo’s flagship Patient SafetyNet across all its patient care areas.

In 2017, Masimo had announced the launch and availability of the Rad-97 Pulse-CO-Oximeter and Next generation SedLine Brain Function Monitoring in India.

Apart from India, the company’s other major emerging market developments include the implementation of Masimo SafetyNet in two hospitals in Dubai under the governance of the Dubai Health Authority (DHA).

Evidently, expanding operations to highly populated economies is a strategic move by Masimo and is likely to fortify the company’s global foothold in the MedTech space.

Promising Market Trends

Per Emergo, the medical devices market in India was worth $3.5 billion in 2015 and is expected to grow to $4.8 billion by 2019. With the evolution of India’s economic, healthcare and social landscapes, the country’s medical devices market is a promising opportunity for foreign manufacturers.

Price Performance

Masimo has underperformed the industry in terms of price. The stock has lost 5.2% against the industry’s rally of 25.6%.

However, positive developments are likely to drive the share price in the quarters ahead.

Zacks Ranks & Key Picks

Masimo carries a Zacks Rank #3 (Hold).

A few better-ranked stocks in the broader medical space are athenahealth, Inc. (NASDAQ:ATHN) , Centene Corporation (NYSE:CNC) and Mednax, Inc. (NYSE:MD) . Each of these stocks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

athenahealth has a projected long-term growth rate of 20.7%. The stock has returned 10% in the past three months.

Centene has a long-term growth rate of 14.4%. The stock has gained 18.9% in the last six months.

Mednax has an expected long-term growth rate of 10%. In the last six months, the stock has gained 26%.

Zacks Top 10 Stocks for 2018

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2018?

Last year's 2017 Zacks Top 10 Stocks portfolio produced double-digit winners, including FMC Corp (NYSE:FMC). and VMware which racked up stellar gains of +67.9% and +61%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2018 today >>

athenahealth, Inc. (ATHN): Free Stock Analysis Report

Masimo Corporation (MASI): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

Mednax, Inc (MD): Free Stock Analysis Report

Original post

NVIDIA Earnings: Can Blackwell Chips Provide Tailwind? By Dave Kovaleski - Feb 25, 2025

The markets have been sluggish this week as investors hope for a jolt later in the week when AI juggernaut NVIDIA Corporation (NASDAQ:NVDA) reports fourth quarter and year-end...

3 Dividend-Paying Stocks Bucking the Market’s Trend By Ryan Hasson - Feb 25, 2025

On Friday, a wave of selling pressure swept across the US equity markets, leaving a trail of losses. The S&P 500 closed down 1.7%, the DOW slid 1.69%, and the NASDAQ tumbled a...

Palantir: Down 30% This Week, Is It Time to Flee the High-Flying... By Alessandro Bergonzi - Feb 25, 2025 6

Palantir remains highly valued with a 460x P/E ratio and a 42.5x P/B ratio, far above its peers. The stock's beta of 2.81 signals high volatility, meaning sharp moves in both...

Add a Comment

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

Write your thoughts here

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

Central Banks

Interest Rates

Next Meeting

FED

4.50%

Mar 19, 2025

ECB

2.90%

Mar 06, 2025

BOE

4.50%

Mar 20, 2025

SNB

0.50%

Mar 20, 2025

RBA

4.10%

Apr 01, 2025

BOC

3.00%

Mar 12, 2025

RBNZ

3.75%

Apr 09, 2025

BOJ

0.50%

Mar 19, 2025

CBR

21.00%

Mar 21, 2025

RBI

6.25%

Mar 10, 2025

PBOC

3.10%

BCB

13.25%

Mar 19, 2025

US 30	43,590.8	+128.9	+0.30%
US 500	5,956.8	-26.7	-0.45%
Dow Jones	43,591.85	+130.64	+0.30%
S&P 500	5,956.90	-26.35	-0.44%
Nasdaq	19,071.40	-215.53	-1.12%
S&P 500 VIX	19.57	+0.59	+3.11%
Dollar Index	106.300	-0.209	-0.20%

Crude Oil WTI	68.83	-1.87	-2.64%
Brent Oil	72.38	-1.93	-2.60%
Natural Gas	4.029	+0.047	+1.18%
Gold	2,918.51	-44.69	-1.51%
Silver	31.838	-0.766	-2.35%
Copper	4.5333	-0.0302	-0.66%
US Soybeans	1,030.63	+1.63	+0.16%

U.S. 10Y	4.303	-0.090	-2.05%
U.S. 30Y	4.558	-0.091	-1.96%
U.S. 5Y	4.131	-0.099	-2.34%
U.S. 3M	4.292	-0.007	-0.16%
US 10Y T-Note	110.50	+0.63	+0.57%
Euro Bund	132.46	+0.63	+0.47%
10-2 Yield Spread	22.59	-0.34	-1.48%

Apple	248.32	+1.22	+0.49%
Alphabet A	176.67	-2.58	-1.44%
Tesla	304.09	-26.44	-8.00%
Amazon.com	208.71	-4.00	-1.88%
Netflix	970.76	-17.71	-1.79%
Meta Platforms	657.05	-11.08	-1.66%
Bank of America	43.83	-0.64	-1.43%

Masimo Products To Boost India-Based NU Hospitals' Systems

Masimo Corporation Price and Consensus

Related Articles